High plasma concentrations of bile acids (BA) and bilirubin are hallmarks of cholestasis. BA are implicated in the pathogenesis of cholestatic liver damage through mechanisms involving oxidative stress, whereas bilirubin is a strong antioxidant. We evaluated the roles of bilirubin and BA on mediating oxidative stress in rats following bile duct ligation (BDL). Adult female Wistar and Gunn rats intraperitoneally anaesthetized with ketamine and xylazine underwent BDL or sham operation. Cholestatic markers, antioxidant capacity, lipid peroxidation and heme oxygenase (HO) activity were determined in plasma and/or liver tissue 5 days after surgery. HepG2-rNtcp cells were used for in vitro experiments. Plasma bilirubin levels in control and BDL animals positively correlated with plasma antioxidant capacity. Peroxyl radical scavenging capacity was significantly higher in the plasma of BDL Wistar rats (210 ± 12%, P < 0.0001) compared to controls, but not in the liver tissues. Furthermore after BDL, lipid peroxidation in the livers increased (179 ± 37%, P < 0.01), whereas liver HO activity significantly decreased to 61% of control levels (P < 0.001). Addition of taurocholic acid (TCA, ≥ 50 μmol/l) to liver homogenates increased lipid peroxidation (P < 0.01) in Wistar, but not in Gunn rats or after the addition of bilirubin. In HepG2-rNtcp cells, TCA decreased both HO activity and intracellular bilirubin levels. We conclude that even though plasma bilirubin is a marker of cholestasis and hepatocyte dysfunction, it is also an endogenous antioxidant, which may counteract the pro-oxidative effects of BA in circulation. However, in an animal model of obstructive cholestasis, we found that BA compromise intracellular bilirubin levels making hepatocytes more susceptible to oxidative damage.

Institute of Clinical Biochemistry and Laboratory Diagnostics Charles University Prague Czech Republic

Zobrazit více v PubMed

Kullak-Ublick GA, Meier PJ. Mechanisms of cholestasis. Clin Liver Dis. 2000;4:357–85. PubMed

Roma MG, Crocenzi FA, Sanchez Pozzi EA. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects. Clin Sci. 2008;114:567–88. PubMed

Guicciardi ME, Gores GJ. Apoptosis: a mechanism of acute and chronic liver injury. Gut. 2005;54:1024–33. PubMed PMC

Maher JJ, Friedman SL. Parenchymal and nonparenchymal cell interactions in the liver. Semin Liver Dis. 1993;13:13–20. PubMed

Sokol RJ, Straka MS, Dahl R, et al. Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids. Pediatr Res. 2001;49:519–31. PubMed

Fuentes-Broto L, Martinez-Ballarin E, Miana-Mena J, et al. Lipid and protein oxidation in hepatic homogenates and cell membranes exposed to bile acids. Free Radic Res. 2009;43:1080–9. PubMed

Sokol RJ, Winklhofer-Roob BM, Devereaux MW, et al. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology. 1995;109:1249–56. PubMed

Moran M, Oruc MT, Ozmen MM, et al. Effect of Erythropoietin on Oxidative Stress and Liver Injury in Experimental Obstructive Jaundice. Eur Surg Res. 2009;43:228–34. PubMed

Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 4th ed. Oxford: Oxford University Press; 2007.

Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043–6. PubMed

Dennery PA, McDonagh AF, Spitz DR, et al. Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia. Free Radic Biol Med. 1995;19:395–404. PubMed

Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis. 2008;198:1–11. PubMed

Ollinger R, Yamashita K, Bilban M, et al. Bilirubin and biliverdin treatment of atherosclerotic diseases. Cell Cycle. 2007;6:39–43. PubMed

Bulmer AC, Blanchfield JT, Toth I, et al. Improved resistance to serum oxidation in Gilbert’s syndrome: a mechanism for cardiovascular protection. Atherosclerosis. 2008;199:390–6. PubMed

Ollinger R, Kogler P, Troppmair J, et al. Bilirubin inhibits tumor cell growth via activation of ERK. Cell Cycle. 2007;6:3078–85. PubMed

Zucker SD, Horn PS, Sherman KE. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology. 2004;40:827–35. PubMed

Vitek L, Schwertner HA. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem. 2007;43:1–57. PubMed

McDonagh AF, Assisi F. The ready isomerization of bilirubin IX- in aqueous solution. Biochem J. 1972;129:797–800. PubMed PMC

Aller MA, Nava MP, Arias JL, et al. Microsurgical extrahepatic cholestasis in the rat: a long-term study. J Invest Surg. 2004;17:99–104. PubMed

Iuliano L, Piccheri C, Coppola I, et al. Fluorescence quenching of dipyridamole associated to peroxyl radical scavenging: a versatile probe to measure the chain breaking antioxidant activity of biomolecules. Biochim Biophys Acta. 2000;1474:177–82. PubMed

Zelenka J, Lenicek M, Muchova L, et al. Highly sensitive method for quantitative determination of bilirubin in biological fluids and tissues. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;867:37–42. PubMed

Maines MD. Current protocols in toxicology. New York: John Wiley; 1998.

Vreman HJ, Wong RJ, Kadotani T, et al. Determination of carbon monoxide (CO) in rodent tissue: effect of heme administration and environmental CO exposure. Anal Biochem. 2005;341:280–9. PubMed

Vreman HJ, Kwong LK, Stevenson DK. Carbon monoxide in blood: an improved microliter blood-sample collection system, with rapid analysis by gas chromatography. Clin Chem. 1984;30:1382–6. PubMed

Vreman HJ, Wong RJ, Sanesi CA, et al. Simultaneous production of carbon monoxide and thiobarbituric acid reactive substances in rat tissue preparations by an iron-ascorbate system. Can J Physiol Pharmacol. 1998;76:1057–65. PubMed

Kullak-Ublick GA, Ismair MG, Kubitz R, et al. Stable expression and functional characterization of a Na+-taurocholate cotransporting green fluorescent protein in human hepatoblastoma HepG2 cells. Cytotechnology. 2000;34:1–9. PubMed PMC

Kotal P, Van der Veere CN, Sinaasappel M, et al. Intestinal excretion of unconjugated bilirubin in man and rats with inherited unconjugated hyperbilirubinemia. Pediatr Res. 1997;42:195–200. PubMed

Wolff DG. The formation of carbon monoxide during peroxidation of microsomal lipids. Biochem Biophys Res Commun. 1976;73:850–7. PubMed

Granato A, Gores G, Vilei MT, et al. Bilirubin inhibits bile acid induced apoptosis in rat hepatocytes. Gut. 2003;52:1774–8. PubMed PMC

Zelenka J, Muchova L, Vitek L. The role of heme oxygenase-1 induction and intracellular metabolism of bilirubin in response to oxidative stress. Hepatology. 2008;48:1124a.

Dumont M, Jacquemin E, D’Hont C, et al. Expression of the liver Na+-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. J Hepatol. 1997;27:1051–6. PubMed

Dulundu E, Ozel Y, Topaloglu U, et al. Grape seed extract reduces oxidative stress and fibrosis in experimental biliary obstruction. J Gastroenterol Hepatol. 2007;22:885–92. PubMed

Huang LT, Tiao MM, Tain YL, et al. Melatonin ameliorates bile duct ligation-induced systemic oxidative stress and spatial memory deficits in developing rats. Pediatr Res. 2009;65:176–80. PubMed

Muchova L, Wong RJ, Hsu M, et al. Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection. Can J Physiol Pharmacol. 2007;85:800–10. PubMed

Naito T, Kuroki S, Chijiiwa K, et al. Bile acid synthesis and biliary hydrophobicity during obstructive jaundice in rats. J Surg Res. 1996;65:70–6. PubMed

Mediavilla MG, Pascolo L, Rodriguez JV, et al. Uptake of [(3)H]bilirubin in freshly isolated rat hepatocytes: role of free bilirubin concentration. FEBS Lett. 1999;463:143–5. PubMed

Geier A, Wagner M, Dietrich CG, et al. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta. 2007;1773:283–308. PubMed

Baranano DE, Rao M, Ferris CD, et al. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA. 2002;99:16093–8. PubMed PMC

Clark JF, Sharp FR. Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2006;26:1223–33. PubMed

Hyperbilirubinemia in Gunn Rats is Associated with Decreased Inflammatory Response in LPS-Mediated Systemic Inflammation

HYCO-3, a dual CO-releaser/Nrf2 activator, reduces tissue inflammation in mice challenged with lipopolysaccharide

Heme Oxygenase-1 May Affect Cell Signalling via Modulation of Ganglioside Composition

Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis